You can access any of the podium or poster presentations’ abstracts by searching for it below. For the 2026 FIP world congress in Montreal, presentations and summaries from invited speakers are available below, while abstracts are published in the Pharmacy Education Journal (PEJ) here.
Export this Abstract | Print this Abstract |
Add to my preferred Abstracts list |
My preferred Abstracts list (0) |
Back to Search
The lfcs consortium: in vitro dispersion tests are an effective first screen during lipid-based formulation development and evaluation
- In: Posters D - Formulation Design and Pharmaceutical Technology
- At: PSWC, Melbourne (Australia) (2014)
- Type: Poster
- Poster code: PD-067
- By: POUTON, Colin (Monash University, Monash Institute of Pharmaceutical Sciences, Parkville, Australia)
- Co-author(s): Williams, Hywel (Monash University, Parkville, Australia)
Anby, Mette (Monash University, Parkville, Australia)
Mcevoy, Claire (Monash University, Parkville, Australia)
Thomas, Nicky (University of Copenhagen, Copenhagen, Denmark)
Calderone, Marilyn (Sanofi R&D, Montpellier, France)
Igonin, Annabel (Capsugel, Illkirch, France)
Vertommen, Jan (Capsugel, Illkirch, France)
Blundell, Ross (Sanofi R&D, Montpellier, France)
Benameur, Hassan (Capsugel, Illkirch, France)
Mullertz, Anette (University of Copenhagen, Copenhagen, Denmark)
Porter, Chris (Monash University, Parkville, Australia) - Abstract:
I. Background: The LFCS Consortium looks to establish standardized in vitro performance tests for lipid-based formulations (LBF).
II. Aims: Here we evaluate the performance of four LBFs containing danazol (DAN), fenofibrate (FFB), tolfenamic acid (TA) or cinnarizine (CIN) on dispersion using different test conditions.
III. Methods: Dispersion.. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 23 September 2026